AMGN vs TASK
Amgen Inc (AMGN) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the AMGN and TASK stock pages for the full models.
Not investment advice.